- $65.90bn
- $80.45bn
- $90.16bn
- 90
- 61
- 77
- 90
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69,693 | 69,217 | 83,959 | 93,512 | 90,155 |
Cost of Revenue | |||||
Gross Profit | 49,150 | 48,595 | 59,403 | 64,279 | 62,456 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 65,227 | 66,800 | 78,495 | 87,267 | 85,243 |
Operating Profit | 4,466 | 2,417 | 5,464 | 6,245 | 4,912 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 655 | 1,669 | 6,674 | 4,896 | 5,363 |
Provision for Income Taxes | |||||
Net Income After Taxes | 465 | 1,286 | 4,952 | 3,826 | 3,972 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 540 | 1,286 | 5,231 | 3,826 | 3,972 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 539 | 1,284 | 5,221 | 3,819 | 3,966 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.63 | 7.54 | 20.9 | 15.6 | 16.8 |
Dividends per Share |